Clinical Trials Directory

Trials / Unknown

UnknownNCT05313828

Effect of Various Treatment Modalities on Dendritic Vial Ulcer

Status
Unknown
Phase
Study type
Observational
Enrollment
40 (estimated)
Sponsor
Sohag University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Eye infection is a prevalent problem in primary care and remains a crucial healthcare concern. According to the American Academy of Ophthalmology (AAO), herpes simplex virus (HSV) keratitis (HSK) is the leading cause of infectious blindness worldwide . HSK is defined as a corneal inflammatory condition caused by the HSV infection . The global incidence of herpetic keratitis is estimated at 1.5 million per year, resulting in 40,000 new cases of severe visual impairment associated with corneal scarring and opacification . HSV type I (HSV-1) is by far the most predominant causative pathogen of eye infections\]. HSV-1 is also known for causing orolabial herpes, HSV folliculitis, herpes gladiatorum, herpetic whitlow, and eczema herpeticum . HSV can be transferred to the eye by touching an active lesion and then the eye. The National Health and Nutrition Evaluation revealed a seroprevalence of HSV-1 in 53.9% of 14-49 year olds, and 90% of adults 50 years or older , indicating that the majority of the population has been exposed to this virus thus are at risk of developing HSK. In this study we evaluate the efficacy of different treatment modalities on viral keratitis HSK.

Conditions

Interventions

TypeNameDescription
DRUGAcycloviracyclovir 4 times /day
DRUGTobramycintobramycin 4 times /day
DRUGFluorometholoneFluorometholone 4 times/ day
DRUGSodium HyaluronateSodium Hyaluronate 4 times/day

Timeline

Start date
2022-03-18
Primary completion
2022-06-28
Completion
2022-07-20
First posted
2022-04-06
Last updated
2022-04-06

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05313828. Inclusion in this directory is not an endorsement.